Substrate
Topic

weight loss drugs

6 stories related to this topic, newest first.

French Regulator Fines Novo Nordisk and Eli Lilly for Weight Loss Drug Advertising Violationsnews18.com
finance22 hrs agoDeveloping

French Regulator Fines Novo Nordisk and Eli Lilly for Weight Loss Drug Advertising Violations

France's medicines regulator imposed fines on Novo Nordisk and Eli Lilly for misleading advertisements related to their weight loss drugs. The penalties come amid launches of oral GLP-1 medications in the U.S., with Novo Nordisk's Wegovy pill gaining early traction. Company execu…

cnbc.com
Stat
2 sources
CMS Launches Medicaid Fraud Crackdown as Insurers Opt Out of Medicare Weight Loss Drug Pilotforbes.com
science13 days agoDeveloping

CMS Launches Medicaid Fraud Crackdown as Insurers Opt Out of Medicare Weight Loss Drug Pilot

The Centers for Medicare & Medicaid Services announced a nationwide effort to combat Medicaid fraud, requiring states to submit provider revalidation plans. Separately, health insurers declined to participate in a Medicare pilot program for discounted weight loss drugs, prompting…

ST
Benzinga
zerohedge.com
3 sources
GLP-1 Weight Loss Drugs Drive Potential $13 Billion Boost in Apparel Retail Spendingcitizen.co.za
finance26 days ago

GLP-1 Weight Loss Drugs Drive Potential $13 Billion Boost in Apparel Retail Spending

Millions of individuals using GLP-1 drugs for weight loss are increasing their purchases of new clothing from retailers. Equity research firm Bernstein estimates this trend could generate up to $13 billion in annual spending for the apparel sector. The development highlights a gr…

cnbc.com
2 sources
Eli Lilly Launches Oral GLP-1 Medication Orforglipron for Weight Loss in the United StatesSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
world26 days ago

Eli Lilly Launches Oral GLP-1 Medication Orforglipron for Weight Loss in the United States

Eli Lilly and Company has introduced Foundayo, the brand name for orforglipron, an oral GLP-1 receptor agonist approved for weight management. The pill offers a non-injectable alternative to existing treatments in the growing obesity drug market. Availability begins in the US, ta…

LI
1 source
Genetic Variants Linked to Weight Loss Outcomes and Side Effects from GLP-1 Drugssciencenews.org
health27 days ago

Genetic Variants Linked to Weight Loss Outcomes and Side Effects from GLP-1 Drugs

A study published in Nature identifies variations in two genes associated with greater weight loss and increased side effects from GLP-1 receptor agonist drugs like Wegovy and Mounjaro. The research, based on data from 15,000 to nearly 28,000 23andMe users, shows modest genetic i…

The Bbc
The Independent
ST
3 sources
Rise in Testing of Unregulated Peptides in UK Amid Weight-Loss and Wellness DemandSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
health29 days ago

Rise in Testing of Unregulated Peptides in UK Amid Weight-Loss and Wellness Demand

Laboratories in the UK and internationally are processing thousands of samples of unregulated peptides sent by consumers for quality verification. These substances, often marketed for weight loss, biohacking, and anti-aging, include experimental compounds like retatrutide, which…

The Guardian
2 sources